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Abstract
Anti-Mu¨llerian hormone (AMH) is a member of the TGF-b superfamily secreted by the gonads of both sexes. This hormone is
primarily known for its role in the regression of the Mu¨llerian ducts in male fetuses. In females, AMH is expressed in
granulosa cells of developing follicles. Like other members of the TGF-b superfamily, AMH transduces its signal through two
transmembrane serine/threonine kinase receptors including a well characterized type II receptor, AMHR-II. The complete
signalling pathway of AMH involving Smads proteins and the type I receptor is well known in the Mu¨llerian duct and in
Sertoli and Leydig cells but not in granulosa cells. In addition, few AMH target genes have been identified in these cells.
Finally, while several co-receptors have been reported for members of the TGF-b superfamily, none have been described for
AMH. Here, we have shown that none of the Bone Morphogenetic Proteins (BMPs) co-receptors, Repulsive guidance
molecules (RGMs), were essential for AMH signalling. We also demonstrated that the main Smad proteins used by AMH in
granulosa cells were Smad 1 and Smad 5. Like for the other AMH target cells, the most important type I receptor for AMH in
these cells was BMPR-IA. Finally, we have identified a new AMH target gene, Id3, which could be involved in the effects of
AMH on the differentiation of granulosa cells and its other target cells.
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Introduction
Anti-Mu¨llerian hormone (AMH) also called Mu¨llerian inhibit-
ing substance (MIS) is a member of the TGF-b superfamily. AMH
is well known for its role in Mu¨llerian duct regression in male
fetuses [1]. In female fetuses, the lack of AMH expression allows
the development of the Mu¨llerian ducts into oviduct, uterus, cervix
and the upper part of the vagina. Postnatally, AMH is secreted by
granulosa cells (GCs) of small growing follicles (preantral and small
antral) [1]. In mice, AMH is a negative regulator of the primordial
to primary follicle transition [2]. In addition it decreases FSH
sensitivity of growing follicles [3]. In clinics, serum AMH is now
widely used in oncology and gynecology. Indeed, it is a very useful
diagnostic and prognostic tool, as an early indicator of relapse of
ovarian GC tumors [4] and as a reliable marker of the ovarian
follicular status. AMH assay is also an important tool to control
ovarian hyperstimulation [5]. However, despite the increasing
interest of ovarian AMH in clinics, little is known on its
mechanism of action on GCs.
Members of the TGF-b family signal through a type II
transmembrane serine/threonine kinase receptor which forms a
complex with a type I serine/threonine kinase receptor [6]. The
type II receptor phosphorylates serine and threonine residues of
type I receptor. Once activated, the type I receptor phosphorylates
the receptor-regulated Smads (R-Smad) which interact with a
common partner Smad4. The Smad complex accumulates into the
nucleus and regulates target gene expression [7]. TGF-b and
activins activate TbetaRI and ActR-IB type I receptors and R-
Smads 2 and 3, whereas Bone Morphogenetic Proteins (BMPs)
mediate their effects through ActR-IA, BMPR-IA and BMPR-IB
type I receptors and R-Smads 1, 5 or 8. This canonical signalling
pathway is regulated at different levels, in particular by co-
receptors which amplify or antagonize TGF-b family members
action.
AMH has a single specific type II receptor (AMHRII, also
known as MISRII) [8,9]. Indeed, Amh and Amhr2 inactivation
causes the same phenotype in males [10], a complete retention of
an ectopic female reproductive tract, indicating that the AMH
type II receptor is the only type II receptor that transduces AMH
signal [11]. Moreover, in human, mutations of AMH or AMHRII
are involved in Mu¨llerian duct derivative persistance [12].
Regarding the other components of AMH signalling pathway, it
was first shown in different cell lines of gonadal origin that AMH
phosphorylates R-Smad 1/5/8, meaning that it uses ActR-IA,
BMPR-IA or BMPR-IB type I receptors to transduce its effects
[13]. Then the disruption of these type I receptors and R-Smads in
mice led to the conclusion that BMPR-IA is the primary type I
receptor required for Mu¨llerian duct regression but that ActR-IA
is capable of transducing the AMH signal in the absence of
BMPR-IA, and that R-Smad 1/5/8 function redundantly [14–
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16]. Similarly, in the immature Sertoli cell line SMAT-1, AMH
mediates its signal through BMPR-IA and ActR-IA [17]. In
contrast, the type I receptors and R-Smads involved in AMH
effects on post-natal GCs remain unknown. In addition, to date,
no co-receptor has been found for AMH. Because AMH share
with BMPs its type I receptors and R-Smad proteins, it could have
the same co-receptors, like the Repulsive Guidance Molecule
(RGM) [18] which were first shown to induce axonal guidance
during neurogenesis [19] and have three isoforms: RGMa, RGMb
(Dragon) and RGMc (Hemojuvelin).
To date, only few AMH target genes have been identified. In
males, AMH inhibits Sertoli and Leydig cells differentiation
through repression of several steroidogenic proteins like P450scc
(Cyp11a1), 3b-HSD (Hsd3b1) or P450C17 (Cyp17a1) [17,20,21].
Little is known on the genes involved in the inhibitory effect of
AMH on GCs differentiation, preventing the study of AMH
mechanism of action on these cells. Aromatase (Cyp19a1) and LH
receptor (Lhcgr) are down-regulated by AMH in rat and porcine
GCs [22]. In human GCs, FSHR (Fshr) is also repressed by AMH
[23] which could explain the inhibitory role of this hormone on
follicles sensitivity to FSH. Because BMPs share their signalling
pathway with AMH and regulate GCs differentiation, BMPs
target genes involved in this process could also be modulated by
AMH. This could be the case for the family of Inhibitor of
differentiation/Deoxyribonucleic Acid-Binding (Id) genes which
are BMP2 and BMP4 target genes in mice [24]. These genes have
been shown recently to be related to the status of GC
differentiation [25]. They lack a domain required for DNA
binding and act as negative antagonists of bHLH transcription
factors and gene expression in mammals [26].
In this study, we used primary GCs isolated from immature
mice to identify target genes and co-receptors potentially
implicated in AMH effects on GCs differentiation and to define
the involvement of the different type I receptors and Smads
proteins in this process. We also took advantage on conditional
mutant mice for different actors of AMH signalling pathway to
confirm our data. Our studies reveal that Id3 is a new AMH target
gene in GCs. In addition, this work indicates that BMPR-IA and
Smad 1/5 are the main components of AMH signalling pathway
in GCs.
Materials and Methods
Ethics Statement
Housing and care, method of euthanasia and experimental
protocols were conducted in accordance with the recommenda-
tions of the French Accreditation of Laboratory Animal Care and
in compliance with the NIH Guide for Care and Use of
Laboratory Animals. The animal facility is licensed by the French
Ministry of Agriculture (agreement NuC92-023-01). All animal
experiments were supervised by Dr. Soazik Jamin (agreement
delivered by the French Ministry of Agriculture for animal
experiment Nu92–299). Animals were sacrificed with CO2. All
efforts were made to minimize animal suffering.
Reagents
Recombinant human AMH was produced from the culture
medium of Chinese hamster ovary (CHO) cells stably transfected
with a human AMH cDNA, purified and cleaved by plasmin
(plasmin-cleaved AMH or PC-AMH) as previously described [27].
PC-AMH subsequently called AMH was used at a concentration
of 8 or 40 nM. BMP2 was a kind gift of Prof. Walter Sebald
(University of Wu¨rzburg, Germany) and was used at a concen-
tration of 10 nM [28]. TGF-b was purchased from R&D Systems
(Lille, France) and used at 1 nM. Smad1-Gal4, Smad5-Gal4,
Smad8-Gal4 and Gal-Luc plasmids were kindly provided by Dr.
Azeddine Atfi (Inserm UMR S938, Paris).
Mice
Immature female C57BL/6JRj mice (3 weeks old) were
purchased at Elevage Janvier (Le Genest-St-Isle, France).
Amhr2-cre [15], Acvr1+/2 [29], Bmpr1a+/2 [30], Acvr1fx/fx [31],
Bmpr1afx/fx [32] mice were maintained on a C57BL/6J; 129/SvEv
mixed genetic background. Amhr2-cre; Acvr1+/2 or Amhr2-cre;
Bmpr1a+/2 males were bred to Acvr1fx/fx or Bmpr1afx/fx females
to generate females that were conditionally null for Acvr1 or
Bmpr1a respectively (designated as Acvr1 cKO and Bmpr1a cKO).
Mouse genotyping
Genomic DNA was extracted from tail biopsies using a
NucleoSpin Tissue kit (Macherey-Nagel, Hoerdt, France) accord-
ing to the manufacturer’s instructions. The primers used to detect
Acvr1 and Bmpr1a alleles are listed Table S1. The amplification
conditions were 95uC for 5 min, followed by 94uC for 45 s, 58uC
for 45 s, and 72uC for 45 s (35 cycles), with a final extension at
72uC for 10 min. The amplified PCR fragments were analysed on
2% agarose gels.
Primary cultures of mouse granulosa cells
The preparation of mouse GCs primary cultures was adapted
from a rat primary GC culture protocol [33]. Immature ovaries
from 3 weeks old mice were collected in RPMI medium
(Invitrogen). Then, they were exposed to 6.8 mM EGTA, 0.2%
BSA in Medium 199 (Invitrogen) for 15 min at 37uC. After a
5 min centrifugation at 500 rpm, ovaries were placed in a
hypertonic solution (0.5 M sucrose, 1.8 mM EGTA, 0.2% BSA)
in Medium 199 for 5 min at 37uC. Three volumes of Medium 199
were added to stop the reaction. After a 5 min centrifugation at
500 rpm, ovaries were placed in DMEM/F-12 medium with 1%
Fetal Bovine Serum (FBS, Life technologies) and GCs were
dissociated with a blunt spatula. Cells were pelleted by a 10 min
centrifugation at 1300 rpm. Supernatant was discarded and cells
were resuspended in DMEM/F-12 without phenol red, 10% FBS.
The collected cells were counted in the presence of Trypan blue
(0.07%) and seeded in DMEM/F-12 without phenol red, 10%
FBS and 1% penicillin/streptomycin (Eurobio, Courtaboeuf,
France) at 37uC in 5% CO2. 36 h after plating, GCs were
exposed to AMH, BMP2 or TGF-b in DMEM/F-12 without
phenol red, 1% FBS and 1% penicillin/streptomycin (Eurobio) for
24 h for RNA analyses. For protein analyses, GCs were starved in
serum-free medium for 1 h prior to a 3 h AMH, BMP2 or TGF-b
exposure.
b-galactosidase and pmaxGFP transfection
Primary GCs seeded in 6-well plates (56105 cells/well) were
transfected using Fugene6 reagent (Roche Diagnostics, Meylan,
France) with 1 mg b-galactosidase reporter gene or pmaxGFP
vector when cells were 80% confluent. After 24 h, b-galactosidase
activity was detected with X-gal staining and GFP signal was
directly visualized.
Immunofluorescence
Cells were seeded in 4-well Lab-Tek (16105 cells/well)
(Dutscher, Brumath, France) and incubated at 37uC in 5%
CO2. After a quick wash in 1X phosphate-buffered saline (PBS),
the cells were fixed in 4% paraformaldehyde (PFA) for 15 min.
After a permeabilization step in tris-buffered saline (TBS)/0.2%
AMH Signalling in Granulosa Cells
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Triton, cells were incubated in blocking buffer (PBS 1X, 10%
BSA, 0.3% Triton) for 1 h at room temperature. Then cells were
incubated with the anti-AMH (1:500, Santa Cruz, Heidelberg,
Germany) primary antibody in dilution buffer (PBS 1X, 1% BSA,
0.3% Triton) overnight at 4uC. After one wash in TBS/Triton,
cells were incubated with the secondary antibody (Alexa Fluor-488
conjugated rabbit antibody) 1 h at room temperature in the dark.
Cells were washed in high salt PBS and slides were covered with
mounting medium containing DAPI (Vector Laboratories, Abcys,
Les Ulis, France).
Immunohistochemistry
Ovaries from 3 weeks old C57BL/6J females were collected and
fixed in 4% PFA for 4 h at 4uC. Samples were then washed with
PBS (pH 7.4), dehydrated in graded ethanol, embedded in
paraffin and cut into 5 mm thick sections. For antigen retrieval,
samples were boiled in citrate buffer 10 mM pH 6.0 at 80uC for
45 min. Thereafter, slides were washed with PBS and blocked with
PBS-BSA 10% for 1 h before an overnight incubation with a
primary anti-RGMb antibody (1:100 in DAKO buffer, Santa
Cruz). Specimens were washed with PBS and incubated with a
secondary biotinylated antibody (anti-rabbit 1:500) 1 h at room
temperature. After washing, slides were incubated 1 h in ABC
reagent (ABC kit, Vectastain, Abcys) and stained with DAB
reagent during 5 min.
siRNA gene knockdown
Small-interfering RNAs (siRNAs) for Acvr1 (59932), Bmpr1a
(160872), Bmpr1b (60258), and a negative control siRNA #1 were
obtained from Ambion (Life Technologies) and siRNA Rgmb
(J05553408) was obtained from Dharmacon (Fisher Scientific,
Illkirch, France). siRNAs were used at a final concentration of
100 nM. Primary GCs seeded in 6-well plates (56105 cells/well)
were transfected using Oligofectamine reagent (Life Technologies)
with 100 nM siRNA when cells were 50% to 80% confluent. The
medium was removed after 3 h and replaced by DMEM/F-12 1%
FBS. The cells were then cultured 3 h or 24 h in the presence of
8 nM AMH.
siRNA GAPDH-cy3 (4390849, Life Technologies) used to show
transfection efficiency was transfected as described above and the
fluorescence was analysed by flow cytometry (FACS Calibur,
Becton Dickinson).
Luciferase Assay
Primary GCs seeded in 6-well plates (56105 cells/well) were co-
transfected with a luciferase reporter (UAS-luc, 300 ng), expres-
sion construct (Smad-Gal4, 200 ng) [34] and pRLTK (1 ng,
Promega) as a control for transfection efficiency. Transfection was
performed using FugeneHD according to the manufacturer’s
instructions (Roche). Cells were subsequently treated 24 h with
AMH (8 nM), washed with PBS and lysed in passive lysis buffer
(Promega). All lysates were analysed for Firefly and Renilla
luciferase activity according to the manufacturer (Dual Luciferase
kit, Promega). Results were expressed as a percentage of
stimulation of Firefly luciferase activity (after normalization to
Renilla luciferase activity) in the presence of AMH compared to
cells cultured in control medium.
RNA isolation and Reverse Transcription
Total RNAs were isolated using the RNeasy Minikit (QIAGEN)
according to the manufacturer’s instructions. Reverse transcription
was performed in a total of 20 ml with the Omniscript Reverse
Transcription Kit for RT-PCR (QIAGEN) using 500 ng or 1 mg
total RNA, Omniscript reverse transcriptase, oligo-dT primers
(1 mM) and random hexamers (10 mM) as recommended by the
manufacturer. The samples were incubated 1 h at 37uC.
PCR amplification
cDNA from primary GCs or total ovary were used to amplify
Inha, Lhcgr, and Fshr by PCR. The primer pairs used are shown
Table S2. PCR was performed using PCR mix (Qiagen). The
amplification conditions were 95uC for 5 min, followed by 35
cycles of 94uC for 45 s, 58uC for 45 s, and 72uC for 45 s, with a
final extension at 72uC for 10 min. The amplified PCR fragments
were analysed on 2% agarose gels.
Quantitative real-time PCR
Quantification of the content of Amhr2, Acvr1, Bmpr1a, Bmpr1b,
Cyp11a1, Fshr, Id3, Inha, Rgma, Rgmb, Rgmc, Smad1, Smad4, Smad5,
Smad8, Star and Hprt mRNA was performed by real-time PCR
using the TaqMan PCR method. The primers and the UPL
probes (Roche Diagnostics, Mannheim, Germany) used to amplify
these genes are indicated Table S2. Real-time PCR was performed
with one fifth dilution of the cDNAs using the Lightcycler 480
Probes Master kit (Roche Diagnostics, Mannheim, Germany).
Primers were used at a concentration of 5 mM and probes at
1 mM. The PCR protocol used an initial denaturating step at 95uC
for 10 min followed by 45 cycles of 95uC for 10 s, 58uC for 30 s,
72uC for 1 s. To generate standard curves, different concentra-
tions of the purified and quantified PCR products were amplified.
Relative gene expression was normalized to an endogenous
control gene (Hprt).
Western blot
Mouse primary GCs were seeded into 6 wells plates at a density
of 56105 cells/well in 2ml of culture medium. Cells were then
harvested, and lysed in 50 mM Tris HCL (pH 7.4)/150 mM
NaCl, 1% protease inhibiting cocktail and 1% Triton. Insoluble
material was removed by centrifugation at 12,0006g, for 5 min at
4uC. The supernatants were recovered, and protein concentrations
were measured using the BCA protein assay kit (Pierce).
Equivalent amounts of protein lysates (8 to 20 mg) were subjected
to 4–20% SDS-PAGE (Biorad) and electrophoretically transferred
onto nitrocellulose membranes. After the blocking of non-specific
binding sites for 1 h in Tris-buffered saline (25 mM Tris and
150 mM NaCl, pH 7.6) containing 5% non-fat milk and 0.1%
Tween 20, the membranes were exposed to the primary antibodies
(anti-phospho-Smad 1/5/8 and anti-phospho-Smad2/3 (Cell
Signalling Technology) both at 1:500) overnight at 4uC. Reactive
proteins were detected with horseradish peroxidase-conjugated
secondary antibodies (1:5000) for 1 h at room temperature and
developed with West Pico Western blotting detection reagents
(Pierce). The membranes were stripped with a stripping buffer
(Pierce), then reprobed with a mouse monoclonal antibody to b-
Actin (Sigma Aldrich) or mouse monoclonal anti-a-Tubulin
(Sigma Aldrich). Western blots were quantified using ImageJ
software.
Statistical analysis
All experimental data are presented as means 6 SEM. Data
were analyzed using t-test or one-way ANOVA followed by Tukey
test for all-pair comparisons to compare respectively two or several
means. A difference was considered statistically significant when
the p-value was ,0.05. * p,0.05, ** p,0.01, *** p,0.001. All
calculations were made using GraphPad Prism 5.1 (GraphPad
Software, La Jolla, CA).
AMH Signalling in Granulosa Cells
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Results
Primary cultures of immature mouse granulosa cells
To identify the different components of the AMH signalling
pathway in GCs, we first isolated immature GCs from 3 weeks old
mice [33] and we characterized them for different criteria.
Immature ovaries are mainly composed of small growing follicles
whose GCs express AMH [35]. Therefore, we used an AMH
antibody coupled to an Alexa fluor-488 secondary antibody to
evaluate the purity of the primary GCs by immunofluorescence
(Fig. 1A and 1B). About 90% of the cells expressed AMH which
indicated an efficient enrichment of GCs (Fig. 1A and 1B). Since
we had to transfect plasmid DNA in GCs, we then assayed
transfection efficiency in these cells using a b-galactosidase
reporter gene (Fig. 1C) or pMax-GFP vector (Fig. 1D). After X-
Gal staining, we found that about 20% of the cells stained
positively for b-galactosidase activity, indicating that they had
been properly transfected (Fig. 1C). The transfection capacity of
the primary GC culture was confirmed with pMax-GFP transfec-
tion by visualizing GFP-expressing cells (Fig. 1D). We also checked
siRNA transfection efficiency. GCs were transfected with a
fluorescently-labelled control siRNA (GAPDH-cy3 siRNA). The
next day, the cells were trypsinized and the cell suspension was
analysed by flow cytometry. We found that 97.5% of the GCs
were transfected with the fluorescent siRNA, demonstrating a high
siRNA transfection efficiency (Fig. 1E). We then checked for the
presence of GCs markers (Fig. 1F). As in the total ovary, GCs
expressed FSH receptor (Fshr) and a inhibin (Inha) (Fig. 1F). On the
other hand, LH receptor (Lhcgr), a theca cell marker at this stage,
was detected in the 3 weeks old ovary, as expected, but absent in
the GCs. These results confirmed that the culture was at least 90%
pure with little or no theca cell contamination.
Granulosa cells can respond to plasmin cleaved AMH
We next studied the expression of the different components of
AMH signalling pathway in GCs. Using real time PCR, we
observed that all of the serine/threonine kinase receptors
candidate genes (Acvr1, Bmpr1a, Bmpr1b and Amhr2) (Fig. 2A) and
the three candidate Smads (Fig. 2B) were expressed in primary
GCs. The results showed that Amhr2 was expressed at higher levels
(between 3.5 and 37 times) than the type I receptors (Fig. 2A),
Bmpr1a being the most represented (Fig. 2A). Among Smads,
Smad4 was the most expressed, the levels of Smad1 and Smad5 were
similar and Smad8 protein was poorly represented (Fig. 2B). We
then tested if primary GCs were responsive to AMH (plasmin-
cleaved AMH). We analysed the response of GCs after a 3 h
exposure to AMH by Western blot using a phospho-Smad 1/5/8
antibody (Fig. 2C). Both AMH and BMP2, which is the primary
inducer, could increase phospho-Smad 1/5/8 levels (Fig. 2C and
2D) while TGF-b had no effect on this pathway. We then checked
if AMH could also activate the alternative Smad2/3 pathway.
TGF-b which is a primary inducer of the Smad 2/3 pathway was
used as a positive control in parallel with AMH (Fig. 2E). As
expected, in the presence of TGF-b, phospho-Smad 2/3 levels
were increased in primary GCs (Fig. 2E and 2F). However, neither
AMH nor BMP2 were able to activate the Smad2/3 pathway
(Fig. 2E and 2F). Thus, the primary GCs displayed all the
characteristics necessary for our study. They expressed all of the
factors of the AMH signalling pathway, they were properly
transfected and they were sensitive to AMH. These primary GCs
were then used for the rest of the studies described in this paper.
AMH target genes in granulosa cells
To monitor AMH signalling, we then screened for downstream
target genes. GCs were treated with AMH (8 nM) during 24 h,
and the expression of candidate genes was analysed by real time
PCR. We first tested AMH target genes previously identified in the
ovary. Aromatase (Cyp19a1) and LH receptor (Lhcgr) were
expressed at very low levels and we were not able to detect any
variation of their expression after AMH exposure (data not
shown). We then studied a inhibin (Inha) (Fig. 3A) and FSH
receptor (Fshr) (Fig. 3B) whose expression was not modulated by
AMH in GCs. Because AMH regulates genes encoding steroido-
genic enzymes in Sertoli and Leydig cells, we tested whether their
expression was also affected by AMH in GCs. 3 b-HSD (Hsd3b1)
expression was too low to detect any variation (data not shown).
Star (Fig. 3C) and P450scc (Cyp11a1) (Fig. 3D) were not regulated
by AMH. Finally, we tested the effect of AMH on Id genes
expression which are known to be up regulated by BMPs. Id1, 2
and 3 were up-regulated by BMP2 in GCs but not by TGF-b (data
not shown). Similarly to BMP2, AMH increased all Id genes
expression but only Id3 gene was significantly up-regulated
(Fig. 3E). After 24 h in the presence of AMH, Id3 expression in
GCs is increased by 50%. Therefore, Id3 gene was used in this
study to assay siRNA knockdown experiments.
Involvement of the different serine/threonine kinase
receptors in AMH signalling
To determine which type I serine/threonine kinase receptor(s)
was important for AMH signalling pathway, we used siRNA for
gene knockdown (Fig. 4). Primary GCs were isolated from
immature ovaries and transfected when 50 to 80% confluence
was reached with different siRNAs against Acvr1, Bmpr1a and
Bmpr1b. After another 24 h of culture, the cells were exposed to
AMH and total RNA were extracted 24 h later. We first checked
the expression of each serine/threonine kinase type I receptor
gene after siRNA transfection using real time PCR (Fig. 4A–C).
For each type I receptor gene, we tested three different siRNAs
(data not shown) and selected the most efficient one for the rest of
the study. siRNA transfection led to a 80% decrease of Acvr1
mRNA levels (Fig. 4A), a 70% decrease for Bmpr1a (Fig. 4B) and a
70% decrease for Bmpr1b (Fig. 4C). Since the down regulation was
significant for each of the genes, we then analysed the
responsiveness of these knocked-down GCs to AMH by Western
blot with a phospho-Smad1/5/8 antibody (Fig. 4D). In parallel,
the GCs were transfected with a negative control siRNA which
does not interfere with any of the targeted RNAs. As expected, the
negative control siRNA had no effect since the transfected cells
could respond to AMH through the activation of the Smad1
pathway (Fig. 4D and 4E). Similarly, the Acvr1 and Bmpr1b
knockdown cells were sensitive to AMH. However, the effect was
not significant for Acvr1 because of the large standard deviation.
On the other hand, in presence of siRNA against Bmpr1a, the
effect of AMH on phospho-Smad1/5/8 levels was reduced
significantly compared to GC transfected with the control siRNA.
This result indicates that BMPR-IA is important for AMH
signalling in GCs (Fig. 4D and 4E). We then analysed the effect of
AMH on Id3 expression in GCs transfected with the different
siRNAs (Fig. 4F). Id3 expression was up-regulated by 83% after
AMH exposure in GCs transfected with control siRNA. Id3 was
also up-regulated by 158% in GCs transfected with siRNA against
Acvr1 and by 76% in GCs transfected with Bmpr1b siRNA. In
contrast, in GCs transfected with siRNA against Bmpr1a, AMH
was unable to up-regulate the expression of Id3. siRNA technology
allowed us to show that BMPR-IA is important to transduce AMH
signal in GCs (Fig. 4D, 4E and 4F).
AMH Signalling in Granulosa Cells
PLOS ONE | www.plosone.org 4 November 2013 | Volume 8 | Issue 11 | e81551
Granulosa cells from Bmpr1a cKO mice no longer
transduce AMH signalling
To confirm the siRNA results, we generated Acvr1 and Bmpr1a
conditional knockout (cKO) mice, using Amhr2-cre line to delete
these genes in GCs. Amhr2+/cre; Acvr1+/2 or Amhr2+/cre; Bmpr1a+/2
males were bred to Acvr1fx/fx or Bmpr1afx/fx females to generate
females that were conditionally null either for Acvr1 or Bmpr1a in
GCs. Amhr2+/cre; Acvr1fx/2 and Amhr2+/cre; Bmpr1afx/2 are
designated Acvr1 cKO and Bmpr1a cKO, respectively. GCs were
isolated from these cKO mice ovaries and we tested the response
of these cells to AMH by Western blot using a phospho-Smad 1/
5/8 antibody. GCs from Acvr1 cKO mice were as sensitive to
AMH as GCs from control mice (Fig. 5A and 5B). In contrast,
GCs from Bmpr1a cKO mice had lost their capacity to respond to
AMH (Fig. 5C and 5D). The effect of AMH on phospho-Smad1/
5/8 level was reduced significantly in GCs from Bmpr1a cKO
compared to WT GCs (Fig. 5D). These results were consistent
with the siRNA experiments and indicated that BMPR-IA was
essential for AMH signalling in GCs.
RGMb is not required for AMH signalling in granulosa
cells
We then tested whether the BMP co-receptors RGMs could also
be AMH co-receptors. We analysed the expression of Rgma, Rgmb
and Rgmc in the ovary and primary GCs by RT-PCR (Fig. 6A) and
q-PCR (Fig. 6B). Rgma and Rgmc expression was detected in total
ovary but not in GCs (Fig. 6A and 6B). In GCs, we only detected
Rgmb (Dragon) (Fig. 6A and 6B). In parallel, we confirmed the
localization of RGMb in the ovary by immunohistochemistry
where it is mainly present in GCs (Fig. 6C). To determine the
potential role of RGMb in these cells, we transfected them with a
siRNA directed against this co-receptor. We first checked whether
this gene was down-regulated by q-PCR (Fig. 6D) and then
analysed the sensitivity of these cells to AMH by Western blot
using a phospho-Smad 1/5/8 antibody (Fig. 6E). siRNA
transfection led to a 90% decrease of Rgmb mRNAs (Fig. 6D).
The Rgmb knockdown GCs were as sensitive to AMH as control
GCs (Fig. 6E and 6F). We then analysed the effect of AMH on Id3
expression in GCs transfected with siRNA against Rgmb (Fig. 6G).
AMH stimulation led to a 60% increased in Id3 expression in GCs
Figure 1. Characterization of granulosa cells in primary culture. Granulosa cells (GCs) were collected from 3 weeks old C57BL/6 mice ovaries
and seeded at a density 16105 cells/well. 24 h later, GCs were incubated without primary antibodies (IgG) for the control condition (A) or with an
anti-AMH antibody (B). The secondary antibody was coupled to FITC and DAPI was used to visualize the nucleus. AMH expression was detected in the
cytoplasm as expected. To asssay the transfection efficiency, primary GCs were transfected either with a b-galactosidase vector (C, 1 mg), pMax-GFP
vector (D, 1 mg) or GAPDH-cy3 siRNA (E). After 24 h, GC were fixed, stained with X-Gal and counterstained with nuclear fast red (C) or fluorescence
was visualized (D). Alternatively, siRNA transfection efficiency was assayed with a GAPDH-cy3 siRNA on isolated GCs using flow cytometry analysis (E).
(F), Markers of immature GCs were analysed by RT-PCR to confirm their status.
doi:10.1371/journal.pone.0081551.g001
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either transfected with control siRNA or not transfected. Id3 also
remained up-regulated by AMH at the same level in GCs
transfected with siRNA against Rgmb. Altogether, these results
showed that AMH can transduce its signal in the absence of
RGMb indicating that this co-receptor was not essential for AMH
signalling pathway in GCs.
Figure 2. AMH activates Smad1 pathway in granulosa cells. GCs were isolated from 3 weeks old mice ovaries and seeded at 56105 cells/well
in 6 wells plates. RNA was extracted to test AMH signalling pathway actors expression. The main known actors were analysed by real time PCR,
including AMH type II and type I receptors (A, n = 6) and Smads proteins (B, n = 6). Data were analyzed using one-way ANOVA followed by Tukey test
for all-pair comparisons. * p,0.05, ** p,0.01, *** p,0.001. GCs were exposed or not to 8 nM AMH, 10 nM BMP2 and 1 nM TGF-b. Proteins were
extracted and analysed by Western blot using a phospho-Smad1/5/8 antibody (C, n = 4) or a phospho-Smad2/3 antibody (E, n = 4). Western blots
were quantified and normalized to actin levels (D, F, n = 4). AMH could only activate the Smad1/5/8 pathway in GCs (C, D) but not the Smad2/3 one’s
(E, F). As controls, BMP2 only phosphorylated the Smad1/5/8 proteins (C, D) while TGF-b activated exclusively the Smad2/3 pathway (E, F). Data were
analyzed using one-way ANOVA followed by Tukey test for all-pair comparisons. * p,0.05, ** p,0.01, *** p,0.001
doi:10.1371/journal.pone.0081551.g002
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Smad1 and 5 are the main Smads used by AMH in GCs
To investigate which Smad was important for AMH signalling
in GCs, we first used siRNA for gene knockdown but we were not
able to decrease Smad expression more than 50% (data not
shown). We then used a reporter gene assay. 24 h after the
preparation of GCs they were transfected with two plasmids: an
expression plasmid which encodes a fusion protein (Smad1-Gal4-
DBD/Smad5-Gal4-DBD or Smad8-Gal4-DBD) and a reporter
plasmid which codes for a luciferase gene placed under the control
of a promoter which contains UAS sequences (UAS-luc). These
sequences are known to specifically bind Gal4 [36]. 24 h after
transfection, the cells were treated during another 24 h with AMH
(8 nM) and luciferase activity was measured (Fig. 7). As a control,
we transfected Gal4-DBD with the reporter plasmid. As shown on
Figure 7, AMH significantly increased Smad1 and Smad5 activity
(110% and 80%, respectively) while it had no effect on Smad8.
These results indicated that Smad1 and Smad5 were equally
important for AMH signalling in GCs.
Discussion
The aim of this study was to define the different actors of AMH
signalling pathway including new target genes in immature GCs.
Figure 3. AMH target genes in granulosa cells. After collecting and seeding, GCs were exposed (&) or not (%) to 8 nM AMH (A–E) for 24 h. The
effect of AMH stimulation on different potential target genes was examined by real time PCR (A–D, n = 4; E, n = 5). Hprt expression was used to
normalize the results. Data were analyzed using paired t-test. * p,0.05. Id3 expression is significantly increased after AMH exposure.
doi:10.1371/journal.pone.0081551.g003
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Figure 4. Involvement of serine/threonine kinase type I receptors. siRNA transfection for each type I receptor gene was performed when
cells were 50% to 80% confluent. 24 h later GCs were exposed (&) or not (%) to 8 nM AMH during another 24 h. The effect of siRNA on target gene
expression was determined by real time PCR (A–C, n = 4). Data were analyzed using ANOVA followed by Tukey test for all-pair comparisons. The effect
of Acvr1, Bmpr1a and Bmpr1b knockdown on AMH sensitivity was analysed by Western blot using a phospho-Smad1/5/8 antibody (D, n = 4) and was
quantified and normalized (E). The effect of Acvr1, Bmpr1a and Bmpr1b knockdown on Id3 expression was analyzed by real-time PCR (F, n = 3). Data
were analyzed using paired t-test. * p,0.05, ** p,0.01, *** p,0.001. Only GCs transfected with siRNA against Bmpr1a present a significant decrease
of AMH response.
doi:10.1371/journal.pone.0081551.g004
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We report that AMH up-regulates Id3, through BMPR-IA and
that only Smad 1/5 are activated by AMH in these cells. We used
in this study primary culture of mouse GCs and when available,
we checked our results on GCs from conditional knockout mice for
type I receptors.
GCs were prepared from 3 weeks old mouse immature ovaries.
At this stage, ovaries are mainly composed of growing follicles
expressing AMH and very few theca cells [22,33]. As expected,
immunocytochemistry showed that more than 90% of the cells
express AMH, indicating that the culture predominantly contains
GCs. Furthermore, these cultures expressed Fshr and Inha but not
Lhcgr, a theca cell marker at this stage. The expression of Fshr is
compatible with the presence of antral follicles at 3 weeks and with
the fact that Fshr is detectable before the follicles become sensitive
to FSH. These GCs were also properly transfected by siRNAs or
plasmids allowing quantitative studies of the AMH signalling
pathway. Finally, they expressed Amhr2, the AMH specific type II
receptor, the three type I receptors and the R-Smads (Smad1
pathway) necessary to respond to AMH [37]. In keeping with this
result, GCs in primary culture maintained their ability to respond
to AMH by activating the Smad1 pathway.
We also addressed whether a new family of BMP co-receptors
[18] the RGMs, RGMa, b (DRAGON) and c (Hemojuvelin), were
expressed by GCs and could be AMH co-receptors. This
hypothesis was based on the fact that BMPs and AMH share
their signalling pathways, and that both RGMs and AMH are
involved in anti-proliferative effects [38–43]. Indeed, Rgmb
knockdown results in enhanced proliferation, adhesion, and
migration in breast cancer cells [42] and in increased migration
and invasion in PC-3 cells [43]. On the other hand, AMH has
been described as a tumor suppressor gene in the mouse testis [41].
Moreover, in vitro studies have shown that AMH inhibits the
growth of ovarian, endometrial and breast cancer cell lines [38–
40]. We report that RGMb is the only RGM expressed in GCs but
that the decrease of its expression using siRNA does not alter
AMH responsiveness, indicating that RGMb is not essential for
AMH signalling in GCs. Unfortunately, Rgmb knockout mice die
within 2 to 3 weeks after birth suffering from immune and
inflammatory disorders, precluding the study of the female
reproductive tract [44].
We had previously shown in the adult mouse GC line AT29C-
U493 that AMH activated the Smad1/5/8 signalling pathway
[45]. Here we seek to identify which one of these Smad was
preferentially phosphorylated and activated by AMH in GCs. We
demonstrated, using reporter genes specific for each Smad, that
only Smad1 and 5 are activated by AMH. Our results are in
agreement with the phenotype of the transgenic models for
Smad1/5/8. Indeed Smad8 knockout mice are viable and fertile
[46–48] and Smad8 is the least expressed Smad in GCs indicating
that this Smad is not important for ovarian physiology. In contrast,
Smad1 and Smad5 function together in the ovary to suppress
ovarian tumorigenesis [49]. Regarding the involvement of Smad
proteins in AMH signalling, partial retention of Mu¨llerian ducts is
observed when Smad5 is inactivated with or without another Smad,
suggesting that Smad5 is the most important Smad required for
Mu¨llerian ducts regression [16]. However, complete Mu¨llerian
Figure 5. Granulosa cells from Bmpr1a cKO mice do not respond to AMH. Amhr2-Cre; Acvr1+/2 or Amhr2-Cre; Bmpr1a+/2 males were bred to
Acvr1fx/fx or Bmpr1afx/fx females to generate females that were conditionally null for Acvr1 (A, n = 3) or Bmpr1a (B, n = 7) in GCs. GCs were exposed (&)
or not (%) to 8 nM AMH. The AMH response was tested in GCs from these cKO mice by Western blot using a phospho-Smad1/5/8 antibody (A,C).
Western blots were quantified and normalized to actin levels (B n= 3, D n= 7). AMH induced the phosphorylation of Smad1/5/8 in GCs from Acvr1
cKO (A, B) mice but not in those from Bmpr1a cKO mice (C, D). Data were analyzed using paired t-test. * p,0.05, a: p= 0.058. Only Bmpr1a conditional
mutant GCs present a significant decrease of AMH response.
doi:10.1371/journal.pone.0081551.g005
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duct retention in males occurs only when the three genes Smad1/
Smad5/Smad8 are conditionally inactivated [16]. Consistently,
using siRNA against the different Smads, we were not able to
decrease Smad expression more than 50% (data not shown).
We then studied which type I receptor was important in the
AMH signalling pathway testing the ability of AMH to phosphor-
ylate R-Smad 1/5/8 and to stimulate Id3 expression in GCs either
transfected with siRNA against Acvr1, Bmpr1a and Bmpr1b, or
extracted from conditional KO mice for Acvr1 or Bmpr1a. We did
not consider Acvrl1, another type I receptor involved in R-Smad 1/
5/8 pathway whose functional ligands are BMP9 and BMP10
[50]. Indeed, previous studies on AMH signalling in different cell
types did not show the involvement of this receptor [13–15,17,51–
53]. We showed that transfection of GCs with siRNA against
Bmpr1a, prevents AMH to induce Smad1/5/8 phosphorylation
and to regulate Id3 expression. The use of corresponding
conditional knockout mice, support these results. GCs isolated
from Bmpr1a cKO mice ovaries do not transduce the AMH signal.
These results indicate that BMPR-IA is the main AMH type I
receptor in GCs. This is also the case for other AMH target cells.
Indeed, BMPR-IA is necessary for AMH to mediate Mu¨llerian
duct regression since only Bmpr1a disruption induces Mu¨llerian
duct retention in mice [15]. Similarly, BMPR-IA is essential for
AMH to activate Smad 1 in the Sertoli cell line SMAT-1 [17] and
to induce Leydig cells differentiation in mice [53]. In keeping with
a role of BMPR-IA in folliculogenesis, the majority of Bmpr1a cKO
female mice are infertile due to a decrease of spontaneous
ovulations and an inhibition of follicular development [24].
Concomitantly, 9 month-old Bmpr1a cKO mutant females
exhibited increased follicular atresia [24]. Interestingly, the Amhr2
KO mice also display a follicular atresia [54].
However, there is a redundancy among the type I receptors to
transduce AMH effects. Indeed, Mu¨llerian duct regression is
blocked in about 50% of the conditional mutant males for Bmpr1a
and occurs normally in 100% of the conditional mutant males for
Acvr1a, but 100% of the males generated completely retained
Mu¨llerian duct derivatives only when both Acvr1a and Bmpr1a are
conditionally inactivated, [16]. These findings indicate that
BMPR-IA is the primary type I receptor required for Mu¨llerian
duct regression but that ActR-IA is capable of transducing the
AMH signal in the absence of BMPR-IA [16]. Similarly, ActR-IA
can compensate for the lack of BMPR-IA in SMAT-1 Sertoli cells
[17]. Here we show that both GCs transfected with siRNA against
Acvr1 or isolated from Acvr1 cKO mice ovaries are able to respond
to AMH. Therefore, in contrast to Mu¨llerian duct, Sertoli and
Leydig cells, ActR-IA does not act as a secondary type I receptor
for AMH in GCs. In addition, BMPR-IB does not have any
compensatory effect in the absence of BMPR-IA. Interestingly,
Bmpr1b KO mice are viable but females are infertile [55]. These
females develop severe defects in cumulus expansion and
insufficient uterine endometrial gland development. To complete
our siRNA results, it would be interesting to study GCs isolated
from Bmpr1b KO mice.
We needed some AMH target genes to validate the siRNA
knockdown experiments. Cyp19a1 and Lhcgr have been described
as AMH target genes in a previous study [22]. However, we were
unable to use them in the current study because their expression
levels were too low in our GCs culture (data not shown), which is
consistent with their stage of differentiation. Because AMH
regulates genes encoding steroidogenic enzymes in Leydig and
Sertoli cells namely Hsd3b1 and Cyp11a1 [20,56], we have assayed
the expression level of these genes after AMH exposure and could
not detect any changes. Finally, since BMPs share some of their
signalling pathway components with AMH, we tested some proven
BMPs target genes. Id genes are BMP2 target genes in osteoblastic
cells [57] and in the breast cancer cell line MCF-7 [58]. These
proteins function as dominant negative basic helix loop helix
(bHLH) transcription factors. They regulate many genes required
for growth and differentiation, through the binding to E-box
sequences located in the promoter of target genes [59]. Id genes
are selectively up or down regulated depending on cell conditions
[60–62]. In the ovine and hen GCs, the exposure to respectively
BMP6 or BMP2 leads to an increase in all Id genes expression
[60,61]. Conversely, activin A has an inhibitory effect on Id gene
expression [61]. Similarly, in porcine GCs expression levels of Id2
and Id3 are regulated by FSH and cumulus-oocyte-complex in an
Figure 6. RGMb is not essential for AMH signalling in granulosa cells. Rgma, b and c expression was analysed by RT-PCR (A) or real time PCR
(B, n = 6). (A) RT-PCR showed that all three Rgm were expressed in the mouse immature ovary (left lane) while Rgmb seemed predominantly
expressed in GCs (right lane) (A). Real-time PCR confirmed that Rgmb was more expressed than Rgma and Rgmc in GCs (B). Data were analyzed using
one-way ANOVA followed by Tukey test for all-pair comparisons. Mouse immature ovary was subjected to immunohistochemistry using an RGMb
antibody (C). The left panel was the control without the primary antibody. The right panel shows that RGMb is expressed in the cytoplasm of
granulosa cells (scale bar = 50 mm; insert, scale bar = 20 mm). siRNA transfection targeting Rgmb was performed when cells were 50% to 80%
confluent (D–G). GCs were exposed (&) or not (%) to 8 nM AMH. Real-time PCR was used to quantify the decrease in Rgmb expression. Rgmb
expression dropped about 75% in GC transfected with the siRNA targeting Rgmb when compared to a control siRNA (D, n = 6). Western blot with a
phospho-Smad1/5/8 antibody (E, n = 4) and real-time PCR on Id3 gene (G, n = 6) showed that the knowkdown of Rgmb does not affect AMH signalling
pathway. Western blots were quantified and normalized from 4 experiments (F, n = 4). Data were analyzed using paired t-test. * p,0.05, ** p,0.01,
*** p,0.001, a: p= 0.074. AMH response was not significantly different between control siRNA and Rgmb siRNA transfected GCs.
doi:10.1371/journal.pone.0081551.g006
Figure 7. Smad1 and 5 are the main Smads activated by AMH
in granulosa cells. GCs were co-transfected with a luciferase reporter
construct (UAS-luc) and different expression constructs (Smad-Gal4).
Four different expression constructs were transfected in combination
with the reporter construct: Smad1-Gal4, Smad5-Gal4, Smad8-Gal4 and
Gal4 as a control. Cells were stimulated (&) or not (%) with 8 nM AMH.
In the absence of AMH, the fusion protein Smad-Gal4 remained in the
cytoplasm which is reflected by a basal expression level of luciferase.
After 24h of treatment with AMH, the Smad-Gal4 protein was
phosphorylated and could translocate into the nucleus and increase
luciferase expression. Firefly luciferase activity measured in control
medium was set to 100 arbitrary units. The results are expressed as a
percentage of stimulation of Firefly luciferase activity measured in the
presence of AMH (n= 3). Data were analyzed using paired t-test. **
p,0.01.
doi:10.1371/journal.pone.0081551.g007
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opposite way [62]. A recent study has demonstrated a functional
relationship between the expression of all Id isoforms and the
status of GC differentiation [25]. In our study, Id3 gene expression
is upregulated by AMH in immature GCs. Interestingly, Lhcgr
expression is inversely correlated with Id3 transcript level in hen
undifferentiated GCs [25]. Because knockout studies have led to
the conclusion that AMH plays an inhibitory role on follicle
maturation [3], Id3 might be one of the genes involved in this
complex process.
In conclusion, using siRNA and transgenic mice for the different
components of the AMH signalling pathway, we have shown that,
like for the other AMH target cells, the most important type I
receptor for AMH in GCs is BMPR-IA. Moreover, the main
Smad proteins used by AMH in these cells are Smad 1 and Smad
5. Finally, we have identified a new AMH target gene in these
cells, Id3, which could be involved in the effects of AMH on the
differentiation of GCs and its other target cells.
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